Edwards K L, Lemke A A, Trinidad S B, Lewis S M, Starks H, Quinn Griffin M T, Wiesner G L
Department of Epidemiology, University of Washington, Seattle, WA 98115, USA.
Public Health Genomics. 2011;14(6):337-45. doi: 10.1159/000324931. Epub 2011 Apr 11.
Researchers often relate personal experiences of difficulties and challenges with Institutional Review Board (IRB) review of their human genetic research protocols. However, there have been no studies that document the range and frequency of these concerns among researchers conducting human genetic/genomic studies.
An online anonymous survey was used to collect information from human genetic researchers regarding views about IRB review of genetic protocols. Logistic regression was used to test specific hypotheses. Results from the national online survey of 351 human genomic researchers are summarized in this report.
Issues involving considerable discussion with IRBs included reconsent of subjects (51%), protection of participants' personal information (39%) and return of results to participants (34%). Over half of the participants had experienced one or more negative consequences of the IRB review process and approximately 25% had experienced one or more positive consequences. Respondents who had served on an IRB were about 80% more likely to report positive consequences of IRB review than their colleagues who had never served on an IRB (p = 0.03). Survey responses were mixed on the need for reconsent before data sharing and risks related to participant reidentification from genomic data.
The results from this study provide important perspectives of researchers regarding genetic research review and show lack of consensus on key research ethics issues in genomic research.
研究人员常常将自身遇到的困难和挑战经历与机构审查委员会(IRB)对其人类基因研究方案的审查联系起来。然而,尚无研究记录在进行人类基因/基因组研究的研究人员中这些担忧的范围和频率。
采用在线匿名调查从人类基因研究人员那里收集有关IRB对基因研究方案审查的看法的信息。使用逻辑回归来检验特定假设。本报告总结了对351名人类基因组研究人员进行的全国在线调查的结果。
与IRB进行大量讨论的问题包括重新征得受试者同意(51%)、保护参与者的个人信息(39%)以及向参与者反馈结果(34%)。超过半数的参与者经历过IRB审查过程带来的一个或多个负面后果,约25%的参与者经历过一个或多个正面后果。曾在IRB任职的受访者报告IRB审查正面后果的可能性比从未在IRB任职的同事高约80%(p = 0.03)。对于数据共享前是否需要重新征得同意以及基因组数据导致参与者被重新识别的风险,调查结果不一。
本研究结果提供了研究人员对基因研究审查的重要观点,并表明在基因组研究的关键研究伦理问题上缺乏共识。